Comparison of Intubation Conditions During Rapid Sequence Induction Obtained With Modified Time Principal Induction With a Standard Intubation Dose of Rocuronium Versus Succinylcholine

Recruiting Phase 4 Interventional Study
Anesthesia
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Prior Safety Data This treatment has already been tested in at least one earlier human trial.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Trial phase
Phase 4
Study type
Interventional
Purpose
Treatment
Participants needed
152 (estimated)
Sponsor
The University of Texas Health Science Center, Houston · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The purpose of this study is to assess and compare conditions for tracheal intubation obtained with modified time principal induction with 0.6 mg/kg rocuronium and 1 mg/kg succinylcholine. Specifically, the investigators will be evaluating ease of laryngoscopy, vocal cord view, vocal cord opening, and movement of limbs and coughing during tracheal intubation in order to assess intubation condition…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * BMI \> 30kg/m2 or Mallampati class III or IV. * Requiring general anesthesia and endotracheal intubation Exclusion Criteria: * Acute and chronic respiratory disorders, including Chronic obstructive pulmonary disease(COPD) and asthma. * The American Society of Anesthesiologis…
Contacts

Lauren M Nakazawa, MD,MBA

713-500-6775

Lauren.M.Nakazawa@uth.tmc.edu

CONTACT

Ellie Tuchaai

713.614.9355

Ellie.J.Tuchaai@uth.tmc.edu

CONTACT